14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.39 $5.20 Wednesday, 24th Apr 2024 AVXL stock ended at $3.41. This is 7.34% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 12.09% from a day low at $3.39 to a day high of $3.80.
90 days $3.39 $6.90
52 weeks $3.39 $10.31

Historical Anavex Life Sciences Corp. prices

Date Open High Low Close Volume
Aug 14, 2023 $8.75 $9.15 $8.61 $9.15 710 397
Aug 11, 2023 $8.94 $9.01 $8.68 $8.82 550 192
Aug 10, 2023 $9.30 $9.89 $8.95 $9.05 1 964 917
Aug 09, 2023 $8.13 $9.46 $8.08 $9.37 3 087 454
Aug 08, 2023 $8.00 $8.07 $7.58 $8.03 1 095 921
Aug 07, 2023 $8.18 $8.21 $7.63 $7.68 1 054 513
Aug 04, 2023 $8.30 $8.50 $8.19 $8.22 618 653
Aug 03, 2023 $8.16 $8.36 $8.11 $8.30 641 219
Aug 02, 2023 $8.04 $8.31 $7.97 $8.22 616 765
Aug 01, 2023 $8.21 $8.23 $7.97 $8.15 659 013
Jul 31, 2023 $7.94 $8.27 $7.94 $8.25 721 908
Jul 28, 2023 $7.70 $7.95 $7.66 $7.93 674 743
Jul 27, 2023 $8.04 $8.06 $7.62 $7.66 1 006 061
Jul 26, 2023 $8.03 $8.09 $7.95 $7.99 455 173
Jul 25, 2023 $8.14 $8.21 $7.93 $8.02 519 740
Jul 24, 2023 $7.91 $8.21 $7.91 $8.17 702 929
Jul 21, 2023 $8.08 $8.17 $7.92 $8.11 763 254
Jul 20, 2023 $8.25 $8.29 $8.00 $8.00 537 450
Jul 19, 2023 $8.38 $8.49 $8.29 $8.33 426 027
Jul 18, 2023 $8.40 $8.57 $8.37 $8.38 406 970
Jul 17, 2023 $8.41 $8.56 $8.27 $8.37 946 778
Jul 14, 2023 $8.46 $8.54 $8.34 $8.42 481 523
Jul 13, 2023 $8.57 $8.62 $8.43 $8.45 398 047
Jul 12, 2023 $8.71 $8.71 $8.44 $8.55 545 909
Jul 11, 2023 $8.63 $8.74 $8.49 $8.61 527 882
Click to get the best stock tips daily for free!

About Anavex Life Sciences Corp.

Anavex Life Sciences . Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica... AVXL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT